15 CRISPR-Cas technologies have provided programmable gene editing tools that have 16 revolutionized research. The leading CRISPR-Cas9 and Cas12a enzymes are ideal for 17 programmed genetic manipulation, however, they are limited for genome-scale interventions. 18
Introduction 35
CRISPR-Cas systems are a diverse group of RNA-guided nucleases 1 that defend prokaryotes 36 against viral invaders 2,3 . Due to their relatively simple architecture, gene-editing applications have 37 focused on Class 2 CRISPR systems 4 (i.e. Cas9 and Cas12a), but Class 1 systems hold great 38 potential for gene editing technologies, despite being more complex 5-7 . The signature gene in 39
Class 1 Type I systems is Cas3, a 3'-5' ssDNA helicase-nuclease enzyme that, unlike Cas9 or 40
Cas12a, degrades target DNA processively 5, 6, [8] [9] [10] [11] [12] [13] . This property of CRISPR-Cas3 systems raises 41
the possibility of its development as a tool for large genomic deletions. 42
43
Organisms from all domains of life contain vast segments of DNA that are poorly characterized, 44 of unknown function, or may be detrimental for fitness. In prokaryotes, these include prophages, 45
plasmids, and mobile islands, while in eukaryotes, large regions of repetitive sequences and non-46
coding DNA are poorly characterized. Methods for generating programmable and rapid large 47 genomic deletions are needed for the study and engineering of these regions, however these are 48 currently inefficient 14 . A methodology that allows for targeted large genomic deletions in any host, 49 either with precisely programmed or random boundaries, would be broadly useful 15 . 50 51 Type I systems are the most prevalent CRISPR-Cas systems in nature 1 , which has enabled the 52 use of endogenous CRISPR-Cas3 systems for genetic manipulation via self-targeting. This has 53 been accomplished in Pectobacterium atrosepticum (Type I-F) 16 , Sulfolobus islandicus (Type I-54
A) 17 , in various Clostridium species (Type I-B) [18] [19] [20] , and in Lactobacillus crispatus (Type I-E) 21 , 55
leading to deletions as large as 97 kb amongst the self-targeted survivor cells 16 . Additionally, two 56 recent studies have repurposed Type I systems for use in human cells, including the 57 ribonucleoprotein (RNP) based delivery of a Type I-E system 22 , and the use of I-E and I-B systems 58
for transcriptional modulation 23 . Here, we repurposed a Type I-C CRISPR system from 59
Pseudomonas aeruginosa for genome engineering in microbes. Importantly, by targeting the 60 genome with a single crRNA and selecting only for survival after editing, this tool is a counter-61 selection-free approach to programmable genome editing. CRISPR-Cas3 is capable of efficient 62 genome-scale modifications currently not achievable using other methodologies. It has the 63 potential to serve as a powerful tool for basic research, discovery, and strain optimization. 64 crRNAs). PCR of genomic DNA confirmed that the yellow cultures had lost this region, while blue-76 green survivors maintained it ( Supplementary Figure 1 ). Three of these PAO1 IC deletion strains 77
were sequenced, revealing deletions of 23.5 kb, 52.8 kb, and 60.1 kb, and each one was bi-78 directional relative to the crRNA target site ( Figure 1D ). This demonstrated the potential for Type 79 I-C Cas3 systems to be used to induce large genomic deletions with random boundaries 80 surrounding a programmed target site. 81
To determine the in vivo processivity of the Cas3 enzyme, we targeted 2 of the 16 extended non-82 essential (XNES) regions >100 kb in length ( Supplementary Table 1 ) identified from a transposon 83 sequencing (TnSeq) data set 27 . The frequency of deletions generated by crRNAs targeting XNES 84 1 and XNES 2 (along with additional targeting of phzM, which is found in XNES 15) was quantified 85
revealing that 20-40 % of the surviving colonies had deletions (Figure 2A ). To understand how 86 cells lacking large deletions had survived self-targeting, three possibilities were considered: i) a 87 cas gene mutation, ii) a PAM or protospacer mutation, or iii) a mutation to the plasmid expressing 88 the crRNA. Three non-deletion survivors from each of the six self-targeting crRNAs had functional 89
cas genes when the self-targeting crRNA was replaced with a phage targeting crRNA 90
( Supplementary Figure 2A) , and target sequencing revealed no mutations. PCR-amplification and 91
sequencing of the crRNA-expressing plasmids isolated from the survivors revealed the primary 92 escape mechanism: recombination between the direct repeats, leading to the loss of the spacer 93
(Supplementary Figure 2B) . The resulting bands from an additional 17 survivors that lacked 94 deletions were also ~60 bp shorter (Supplementary Figure 2C) , consistent with the loss of one 95
repeat and spacer. 96
Spacer excision was successfully prevented by engineering a modified repeat (MR), with six 97 mutated nucleotides in the stem and three in the loop of the second repeat ( Figure 2B ), disrupting 98 homology between the two direct repeats. A phage-targeting crRNA with this new design targeted 99 phage as well or better than the same crRNA with unmodified repeats (Supplementary Figure  100 3A). Using the same self-targeting spacers designed against phzM, XNES 1, and XNES 2 with 101 the MR resulted in a robust increase in editing efficiencies to 94-100% for the six tested crRNAs 102 ( Figure 2A ) and spacer excision was no longer detected. 211 of 216 (98 %) total survivor cells 103 had large deletions based on PCR screening (i.e. > 1 kb), while the remaining 5 had inactive 104
CRISPR-Cas systems when tested with the phage-targeting crRNA (Supplementary Figure 3B ). 105
The processivity of Cas3 could likely lead to unintended deletions of neighboring essential genes, 106
if targeting is initiated nearby. To assess the phenotype of such an event, we intentionally targeted 107 an essential gene, rplQ (a 50S ribosomal subunit protein 28 ). Two different MR crRNAs targeting 108 rplQ led to a severely extended lag time compared to non-essential gene targeting. Only 8 out of 109 36 rplQ-targeting biological replicates grew after 24 hours, compared to the transient growth delay 110 of ~12 hours when targeting non-essential genes (Supplementary Figure 4A ). Subsequent 111 analysis of these 8 survivor cultures with phage targeting assays revealed non-functional cas 112 genes (Supplementary Figure 4B ). Importantly, no spacer excision events were detected in this 113 experiment or among the 216 replicates screened above. This experiment highlights the 114 robustness of the deletion method, as the outcome of essential gene versus non-essential gene 115
targeting is noticeably distinct. 116
Comparison of Cas3 and Cas9 based editing 117
To determine whether large deletions are a direct consequence of the Cas3 enzyme, we 118 compared self-targeting outcomes to an isogenic strain expressing the non-processive 119
Streptococcus pyogenes Cas9, PAO1 IIA . Two crRNAs (as sgRNAs) that partially overlapped with 120 the crRNAs used for PAO1 IC were targeted to phzM (Figure 2E , Supplementary Figure 5 ). PCR 121 and sequencing analysis of these surviving cells revealed that deletions larger than 1 kb are a 122 rare occurrence (5.6 % assayed survivor cells, n = 72) compared to 98.6 % with PAO1 IC (Figure  123 2E). The more common modes of survival were small deletions between 0.2 -0.5 kb in length 124
(19.4 % of all survivors), or 1-3 bp protospacer/PAM deletions/mutations (25 %). Whole-genome 125 sequencing (WGS) of two large deletion survivors selected for by Cas9 showed lesions of 5 kb 126
and 23 kb around the target site, respectively. The frequent isolation of small deletions from 127
targeting with the non-processive SpyCas9 directly implicates Cas3's enzymatic activity as the 128 cause of large deletions. 129
The direct relationship between Cas3 nuclease-helicase activity and survival via large deletions 130 led us to hypothesize that its processive ssDNA nuclease activity may promote recombination.
131
To test this, we provided a repair template with ~500 bp of the upstream and downstream regions 132
flanking the desired deletion to enable homology directed repair (HDR). We chose 0.17 kb and 133 56.5 kb deletions around phzM and a 249 kb deletion within XNES8 for the programmed deletions 134
(Supplementary Figure 6 ). The recombination efficiencies were significantly higher with Cas3 than 135
with Cas9 ( Figure 2F ). The 249 kb deletion was incorporated in 22 % of the Cas3-generated 136
survivors, compared to 0% using Cas9 ( 2 (1, N = 72) = 9, p = 2.7E-03). The 56.5 kb deletion had 137 an efficiency of 61 % vs. 5.5 % ( 2 (1, N = 72) = 25, p = 5.73E-07), and the 0.17 kb deletion had 138 an efficiency of 100 % vs. 39 % when targeting with Cas3 or Cas9, respectively ( 2 (1, N = 72) = 139 31.68, p = 1.82E-08). These data support the hypothesis that Cas3 enhances recombination at 140 cleavage sites. 141
Rapid genome minimization of P. aeruginosa using CRISPR-Cas3 editing 142
Large deletions with undefined boundaries provide an unbiased mechanism for genome 143 streamlining, screening, and functional genomics. To demonstrate the potential for Cas3, we 144 aimed to minimize the genome of P. aeruginosa through a series of iterative deletions of the XNES 145 regions ( Figure 3A ). Six XNES regions (including XNES 15, carrying phzM) were iteratively 146 targeted in six parallel lineages ( Figure 3B ), resulting in 35 independent deletions (WGS revealed 147 no deletion at XNES 2 in one of the strains). Deletion efficiency remained high (> 80 %) throughout 148 each round of self-targeting ( Supplementary Figure 7) . WGS of these 6 multiple deletion strains 149 (∆61 -∆66) revealed that no two deletions had the exact same coordinates, highlighting the 150 stochastic nature of the process. The smallest isolated deletion was 7 kb and the largest 424 kb 151
(mean: 92.9 kb, median: 58.2 kb). Of note, 4 genes (PA0123, PA1969, PA2024, and PA2156) 152
previously identified as essential 27 were deleted in at least one of the lineages. Most deletions 153 appeared to be resolved by flanking microhomology regions ( Supplementary Table 2 ), implicating 154
alternative-end joining 29 as the dominant repair process. 155
To minimize the genome further, one of the already reduced strains was subjected to 4 additional 156 rounds of deletions at XNES regions for a total of 10 genomic deletions (∆10, Figure 3B ). Whole-157 genome sequencing of the ∆10 strain showed a genome reduction of 849 kb (13.55 % of the 158 genome). Generation of large deletions resulted in a growth defect in some cases, with 159 significantly slower growth in 3 of the 6 deletions strains (∆61, ∆63, and ∆64), with the other 3 160 growing normally ( Figure 3C ). ∆10 also displayed a decrease in fitness, showing a ~15 % increase 161 in doubling time compared to the parent strain. The general subtlety of the growth defects was 162 likely bolstered by the selection of fast-growing colonies at each round of deletion. 163
CRISPR-Cas3 editing in distinct bacteria 164
To enable expression of this system in other hosts, we constructed an all-in-one vector 165
(pCas3cRh) carrying the I-C specific crRNA with a modified repeat sequence and cas3, cas5, 166
cas8, and cas7 (Supplementary Figure 8A) . As a pilot experiment, we transformed wild-type 167 PAO1 with a non-targeting crRNA and crRNAs targeting phzM and XNES2. Induction of the 168 targeting crRNAs induced editing efficiencies between 95-100 % (Supplementary Figure 8B -D). 169
Having verified that pCas3cRh was functional, we tested this system in the model organism 170
Escherichia coli K-12 MG1655. crRNAs were designed to target lacZ or its vicinity ( Figure 4A ), 171
where it is flanked by non-essential DNA (124.5 kb upstream, 22.4 kb downstream).
172
Transformations were plated directly on inducing media containing X-gal and scored using 173
blue/white screening. Depending on the crRNA used, directly targeting lacZ or 30 kb upstream 174 yielded 51-90% or 82-85% editing efficiencies, respectively ( Figure 4B ). 95 of the 96 LacZ (-) 175
survivors assayed by PCR showed an absence of the lacZ region. crRNAs downstream of lacZ, 176
however, had reduced efficiency as they approached the essential gene, hemB. frmA targeting 177
(13 kb downstream of lacZ) had lower editing efficiencies (21-25 %) and yaiS (18 kb downstream 178 of lacZ) even lower (2%). This drop in efficiency was independent of the strand being targeted 179
(and therefore the predicted strand for Cas3 loading and 3'-5' translocation), confirming the 180 importance of Cas3 bi-directional deletions. Indeed, WGS of selected lacZ cells revealed bi-181 directional deletions ranging from 17.5-106 kb encompassing the targeted region ( Figure 4C) . 182
Next, we tested Cas3-mediated editing in the plant pathogen Pseudomonas syringae pv. tomato 183 DC3000, which does not naturally encode a CRISPR-Cas system 30 . P. syringae encodes many 184 non-essential virulence effector genes whose activities are difficult to disentangle due to their 185 redundancy 31 . We designed crRNAs targeting four chromosomal virulence effector clusters (IV, 186 VI, VIII, and IX), or one plasmid cluster (pDC3000 32 , cluster X) in P. syringae strain DC3000. Two 187 clusters (IV and IX) shared identical sequences that could be targeted simultaneously using a 188 single crRNA. Expression of targeting crRNAs led to a noticeable growth delay compared to non-189 targeted controls ( Figure 4D ). PCR analysis of surviving cells showed editing efficiencies of 67-190 92% (Supplementary Figure 9A) . In planta and in vitro growth assays of three deletion mutants 191 effectively recapitulated the phenotypes of previously described cluster deletion polymutants 32 192
( Figure 4E , Supplementary Figure 9B -G). Targeting cluster X cured the 73 kb plasmid and 193 simultaneous cluster IV and IX targeting led to dual deletions in 8 out of 12 survivors, with a 194 sequenced representative having 68.5 kb and 55.3 kb deletions, respectively, at the expected 195 target sites. The effector cluster VI Cas3-derived mutant had a more severe growth defect in vitro 196
and in planta than the control mutant ( Figure 4E , Supplementary Figure 9B ,9E). This large 197 deletion (100.1 kb in size) likely impacted general fitness ( Figure 4F ), demonstrating one 198 drawback of large deletions, but this can be easily overcome by assessing in vitro growth of 199 multiple isolates. Using our portable minimal system, we achieved three new applications: the 200 single-step deletion of large virulence regions, multiplexed targeting, and plasmid curing. Overall, 201
we have demonstrated I-C CRISPR-Cas3 editing to be a generally applicable tool capable of 202 generating large genomic deletions in three distinct bacteria. 203
Repurposing endogenous CRISPR-Cas3 systems for gene editing 204
Type I CRISPR-Cas3 systems are the most common CRISPR-Cas systems in nature 1 . Therefore, 205 many bacteria have a built-in genome editing tool to be harnessed. We first tested the 206 environmental isolate from which our Type I-C system was derived. Introduction of the self-207
targeting phzM crRNA led to the isolation of genomic deletions at the targeted site according to 208
PCR analysis in 0-30% of survivors when wild-type repeats flanked the spacer and 30-60% of 209
survivors when modified repeats were used (Supplementary Figure 10A ). Whole-genome 210 sequencing of two of these isolates revealed 33.7 (wild-type repeat) and 39 kb (MR) deletions of 211 the target gene and surrounding regions ( Figure 5A ). Additionally, HDR-based editing with a 212 single construct was again efficacious, with 7/10 survivors acquiring the specific 0.17 kb deletion 213
(Supplementary Figure 10B ). Together, these experiments demonstrate the capacity for different 214 forms of genome editing using a single plasmid and an endogenous CRISPR-Cas system. 215
We next evaluated the feasibility of repurposing other Type I systems, using the naturally active 216
Type I-F systems 33 encoded by laboratory strain P. aeruginosa PA14, and the clinical strain P. 217 aeruginosa z8. Plasmids with Type I-F specific crRNAs were expressed, targeting various 218 genomic sites for deletion ( Supplementary Table 3 ). HDR templates (600 bp arms on average) 219
were included in the plasmids to generate deletions of defined coordinates ranging from 0.2 to 220 6.3 kb. Overall, at 5 different genomic target sites in strain z8 and 2 sites in PA14, we observed 221 desired deletions in 29 -100 % of analyzed survivor colonies ( Figure 5B ). This demonstrates a 222
high recombination efficiency and the feasibility of repurposing other Type I CRISPR-Cas3 223 systems in the manner we employed for the minimal I-C system. 224
Finally, one potential impediment to the implementation of any CRISPR-Cas bacterial genome 225 editing tool is the presence of anti-CRISPR (acr) proteins that inactivate CRISPR-Cas activity 34 . 226
In the presence of a prophage expressing AcrIC1 (a Type I-C anti-CRISPR protein 26 ) from a native 227 acr promoter, self-targeting was completely inhibited, but not by an isogenic prophage expressing 228 a Cas9 inhibitor AcrIIA4 35 ( Figure 5C ). To attempt to overcome this impediment, we expressed 229 aca1 (anti-CRISPR associated gene 1), a direct negative regulator of acr promoters, from the 230 same construct as the crRNA. Using this repression-based "anti-anti-CRISPR" strategy, CRISPR-231
Cas function was re-activated, allowing the isolation of edited cells despite the presence of acrIC1 232
( Figure 5C and Supplementary Figure 10C ). In contrast, simply increasing cas gene and crRNA 233 expression did not overcome AcrIC1-mediated inhibition ( Figure 5C ). Therefore, using anti-anti-234
CRISPRs presents a viable route towards enhanced efficiency of CRISPR-Cas editing and 235
necessitates continued discovery and characterization of anti-CRISPR proteins and their cognate 236
repressors. 237
Discussion 238
By repurposing a minimal CRISPR-Cas3 system as both an endogenous and heterologous 239 genome editing tool, we show that hurdles to generating large deletions can be overcome. We 240 obtained high efficiencies after modifying a repeat sequence to prevent spacer loss. Using only a 241 single crRNA, we isolated deletions as large as 424 kb without requiring the insertion of a 242 selectable marker or HDR templates guiding the repair process. Additionally, the I-C system 243 appears to produce bi-directional deletions, similar to what was previously observed with the I-F 244 CRISPR-Cas3 system 36,37 , but not with type I-E 9,10,22 . CRISPR-Cas3 presents a genome editing 245 tool useful for the targeted removal of large elements (e.g. virulence clusters, plasmids) and also 246
for unbiased screening and genome streamlining. As a long-term goal of microbial gene editing 247 has been genome minimization 38,39,57 , we used our optimized CRISPR-Cas3 system to generate 248 ten iterative deletions, achieving >13 % genome reduction of the targeted strain. This spanned 249
only 30 days while maintaining editing efficiency, a great improvement over previous genome 250 reduction methods 40 . Some basic microbial applications of Cas3 include studying chromosome 251
biology (e.g. replichore asymmetry 41 ), virulence factors 42 , and the impact of the mobilome. 252
An important outcome of this work is the enhanced recombination observed at cut sites when 253
comparing Cas3 and Cas9 directly. The potential for Cas3 to be more recombinogenic through 254
the generation of exposed ssDNA may be advantageous for both programmed knock-outs and 255
for programmed knock-ins. The direct comparison between Cas3 (large deletions) and Cas9 256
(small deletions) presented here confirms the causality of Cas3 in the deletion outcomes. 257
Our study has revealed some of the benefits and challenges of working with CRISPR-Cas3. While 258 some of the iteratively edited strains demonstrated slight growth defects, the Cas3 editing 259
workflow shows high potential for genome minimization efforts. Since many distinct deletion 260 events are generated, screening various isolates for fitness benefits or defects is possible, and 261 one can proceed with the strain that has the desired fitness property. Additionally, if the location 262 of essential genes within an organism's genome is not fully described, this is not an impediment 263
as editing efficiency drops precipitously when targeting near essential genes. Finally, despite our 264 success at transplanting the minimal Type I-C system, it remains to be seen whether the approach 265 will be limited by differences in DNA repair mechanisms. Indeed, in E. coli and P. syringae, larger 266
regions of homology, such as 34 bp long REP sequences were observed, indicating the role of 267
RecA-mediated homologous recombination 43 in the repair process. Meanwhile in P. aeruginosa, 268
the borders of the deletions showed either small (4-14 bp) micro-homologies or no noticeable 269 sequence homology. The former implies a role for alternative end-joining 29 , while the latter non-270
homologous end-joining 44 in the repair process. Downstream studies are required to dissect the 271 roles of each mechanism in the deletion generation process for better predictable deletion 272
outcomes. 273 CRISPR-Cas3 is an especially promising tool for use in eukaryotic cells as it would facilitate the 274 interrogation of large segments of non-coding DNA, much of which has unknown function 45 . 275
Additionally, it was recently shown that Cas9-generated "gene knockouts" (i.e. small indels 276
causing out-of-frame mutations) frequently encode pseudo-mRNAs that may produce protein 277 products, necessitating methods for full gene removal 46,47 . Encouragingly, a Type I-E CRISPR-278
Cas system was recently delivered to human cells as a ribonucleoprotein (RNP) complex and 279 resulted in large deletions 22 , demonstrating the feasibility of Cas3-mediated editing in human 280 cells. Overall, the intrinsic properties of Cas3 make it a promising tool to fill a void in current gene 281 editing capabilities. Employing Cas3 to make large genomic deletions will facilitate the 282 manipulation of repetitive and non-coding regions, having a broad impact on genetics research 283 by providing a tool to probe genomes en masse, as well as the capability to rapidly streamline 284 genomes for synthetic biology. 285
Methods 287
Bacterial strains, plasmids, DNA oligonucleotides, and media 288 A previously described 26 environmental strain of Pseudomonas aeruginosa was used as a 289
template to amplify the four cas genes of the Type I-C CRISPR-Cas system genes (cas3, cas5, 290 cas7, and cas8). The genes were cloned into the pUC18-mini-Tn7T-LAC vector 48 using the SacI-291
PstI restriction endonuclease cut sites in the order cas5, cas7, cas8, cas3 to generate the plasmid 292 pJW31 (Addgene number: 136423). This vector was introduced into Pseudomonas aeruginosa 293 PAO1 49 , inserting the cas genes into the chromosome, following previously described methods 50 . 294
Following integration, the excess sequences, including the antibiotic resistance marker, were 295
removed via Flp-mediated excision as described previously 50 . The resulting strain, dubbed 296 PAO1 IC , allowed for inducible expression of the I-C system through induction with isopropyl -D-297
1 thiogalactopyranoside (IPTG). An isogenic strain carrying Cas9 derived from Streptococcus 298 pyogenes was constructed in the same fashion, resulting in the strain PAO1 IIA . For experiments 299 to test the system in Pseudomonas syringae, we employed the previously characterized strain 300 DC3000 30 . E. coli editing experiments were conducted with strain K-12 MG1655 51 . 301
To achieve genomic self-targeting of the I-C CRISPR-Cas strains, crRNAs designed to target the 302 genome were expressed from the pHERD20T and pHERD30T shuttle vectors 52 . So-called "entry 303
vectors" pHERD20T-ICcr and pHERD30T-ICcr were first generated by cloning at the EcoRI and 304
HindIII sites an annealed linear dsDNA template carrying the I-C CRISPR-Cas system repeat 305 sequences flanking two BsaI Type IIS restriction endonuclease recognition sites. Additionally, a 306
preexisting BsaI site in a non-coding site of the pHERD30T and pHERD20T plasmids was 307 mutated using whole-plasmid amplification so it would not interfere with the cloning of the 308 crRNAs 26 . Oligonucleotides with repeat-specific overhangs encoding the various spacer 309 sequences were annealed and phosphorylated using T4 polynucleotide kinase (PNK) and cloned 310
into the entry vectors using the BsaI sites. For experiments using Cas9, sgRNAs were expressed 311 from the same pHERD30T vector, with the sgRNA construct cloned using the same restriction 312 sites as with the I-C crRNAs. 313
The all-in-one vector pCas3cRh (Addgene number 133773) is a derivative of the pHERD30T-IC 314 plasmid, with the 4 I-C system genes cloned downstream of the crRNA site. This was achieved 315 by amplifying the genes cas3, cas5, cas8, and cas7 in two fragments with a junction within cas8 316 designed to eliminate an intrinsic BsaI site with a synonymous point mutation. The amplified 317 fragments were cloned into pHERD30T-IC using the Gibson assembly protocol 53 . Finally, to guard 318 against potential leaky toxic expression, we replaced the araC-ParaBAD promoter with the 319 rhamnose-inducible rhaSR-PrhaBAD system 54 . The sequence for rhaSR-PrhaBAD was amplified 320 from the pJM230 template 54 , provided by the lab of Joanna B. Goldberg (Emory University), and 321
cloned into the pHERD30T-IC plasmid to replace araC-ParaBAD using Gibson Assembly (New 322
England Biolabs). Without induction, transformation efficiencies of targeting constructs of 323 assembled pCas3cRh were on average 5-10-fold lower when compared to non-targeting controls 324
(Supplementary Figure 8C) , indicating residual leakiness of the I-C system. 325
The aca1-containing vector pICcr-aca1 is a derivative of the pHERD30T-ICcr plasmid, with aca1 326 cloned downstream of the crRNA site under the control of the pBAD promoter. The aca1 gene 327
was cloned from P. aeruginosa phage DMS3m. 328
All oligonucleotides used in this study were obtained from Integrated DNA Technologies. For a 329 complete list of all DNA oligonucleotides and a short description, see Supplementary Table 4 . 330 P. aeruginosa and E. coli strains were grown in standard Lysogeny Broth (LB): 10 g tryptone, 5 g 331 yeast extract, and 10 g NaCl per 1 L dH2O. Solid plates were supplemented with 1. 
Genomic targeting 372

Pseudomonas aeruginosa 373
Genomic self-targeting of P. aeruginosa PAO1 IC was achieved by electroporating cells with 374
pHERD30T (or pHERD20T) expressing the self-targeting spacer of choice. Cells were plated onto 375 LB agar plates containing the selective antibiotic, without inducers, and grown overnight. Single 376 colonies were then grown in liquid LB media containing the selective antibiotic, as well as IPTG 377
to induce the genomic expression of the I-C system genes, and arabinose to induce the 378 expression of the crRNA from the plasmid. The aca1-containing crRNA plasmids do not need 379 additional inducers, as the pBAD promoter controls aca1. Cultures were grown at 37 °C in a 380
shaking incubator overnight to saturation, then plated onto LB agar plates containing the selecting 381 antibiotic, as well as the inducers, and incubated overnight again at 37 °C. The resulting colonies 382
were then analyzed individually using colony PCR for any differences at the targeted genomic 383 site compared to a wild-type cell. gDNA was isolated by resuspending 1 colony in 20 l of H2O, 384
followed by incubation at 95 °C for 15 min. 1-2 l of boiled sample was used for PCR. The primers 385
used to assay the targeted sites were designed to amplify genomic regions 1.5 -3 kb in size. In 386 the event of a PCR product equal to or smaller than the wild-type fragment (as was often observed 387 when analyzing Cas9-targeted cells), Sanger sequencing (Quintara Biosciences) was used to 388 determine any modifications of the targeted sequences. In some cases, additional analysis of the 389 crRNA-expressing plasmids of the surviving colonies was also performed, by isolating and 390
reintroducing the plasmids into the original I-C CRISPR-Cas strain, where functional self-targeting 391 could be determined based on a significant increase in the lag time of induced cultures, 392 characteristic of self-targeting events. 393
Escherichia coli 394
Genomic self-targeting of E. coli was conducted in a similar fashion as P. aeruginosa, except 395
using the pCas3cRh all-in-one vector. Electrocompetent E. coli cells were transformed with 396 pCas3cRh expressing a crRNA targeting the genome. Individual transformants were selected and 397 grown in liquid LB media containing the selecting antibiotic (gentamicin) overnight without any 398 inducers added. The overnight cultures were then plated in the presence of inducer and X-gal to 399 screen for functional lacZ (LB agar + 15 g/ml gentamicin + 0.1 % rhamnose + 1 mM IPTG + 20 400 g/ml X-gal) and blue/white colonies were counted the next day. 401
Pseudomonas syringae 402
Electrocompetent P. syringae cells were also transformed with pCas3cRh plasmids targeting 403 selected genomic sequences. Initial transformants were plated onto KB agar + 100 g/ml 404 rifampicin + 50 g/ml gentamicin plates, and incubated at 28 °C overnight. Single colony 405 transformants were then selected and inoculated in KB liquid media supplemented with rifampicin, 406 gentamicin, and 0.1 % rhamnose inducer, and grown to saturation in a shaking incubator at 28 407 °C. Cultures were finally plated onto KB agar plates with rifampicin, gentamicin, and rhamnose 408 and incubated at 28 °C. Individual colonies were finally assayed with colony PCR to determine 409 the presence of deletions at the targeted genomic sites. 410 411
Iterative genome minimization 412
Iterative targeting to generate multiple deletions in the P. aeruginosa PAO1 IC strain was carried 413 out by alternating the pHERD30T and pHERD20T plasmids each expressing different crRNAs 414 targeting the genome. Each crRNA designed to target the genome was cloned into both the 415 pHERD30T plasmid, which confers gentamicin resistance, as well as the pHERD20T plasmid, 416
which confers carbenicillin resistance. After first transforming and targeting with a pHERD30T 417 plasmid expressing a specific crRNA, deletion candidate isolates were transformed with a 418
pHERD20T expressing a crRNA targeting a different genomic region. As the two plasmids are 419
identical with the exception of the resistance marker, this eliminated the necessity for curing of 420 the original plasmid to be able to target a different region. For the next targeting event, the 421 pHERD30T plasmid could again be used, this time expressing another crRNA targeting a different 422 genomic region. In this manner, pHERD30T and pHERD20T could be alternated to achieve 423 multiple deletions in a rapid process. At each new transformation step, the cells were checked for 424
any residual resistance to the given antibiotic from a previous cycle. Additionally, functionality of 425 the CRISPR-Cas system of the edited cells could be determined through the introduction of a 426 plasmid expressing crRNA targeting the D3 bacteriophage 34 , then performing a phage spotting 427
assay to see if phage targeting was occurring or not. 428 429
Measurement of growth rates 430
Pseudomonas aeruginosa 431
Growth dynamics of various strains were measured using a Synergy 2 automated 96-well plate 432 reader (Biotek Instruments) and the accompanying Gen5 software (Biotek Instruments).
433
Individual colonies were picked and grown overnight in 300 l volumes of LB in 96-well deep-well 434
plates at 37 °C. The grown cultures were then diluted 100-fold into 100 l of fresh LB in a 96-well 435 clear microtitre plate (Costar) and sealed with Microplate sealing adhesive (Thermo Scientific).
436
Small holes were punched in the sealing adhesive for each well for increased aeration. Doubling 437 times were calculated as described previously 56 . 438
Pseudomonas syringae 439
To test bacterial growth in planta, we used the Arabidopsis thaliana ecotype Columbia (Col-0), 440
which has previously been shown to be susceptible to infection by P. syringae DC3000. Plants 441
were grown for 5-6 weeks in 9h light/15h darkness and 65 % humidity. For each inoculum, we 442 measured bacterial growth in 10 individual Col-0 plants. Four leaves from each plant were 443 infiltrated at OD600 = 0.0002, and cored with a #3 borer. for a 150 bp paired-end sequencing run using the MiSeq sequencer (Illumina). P. syringae and 481
Cas9-generated P. aeruginosa deletion strains were sequenced using a NextSeq 500 Reagent 482
Kit v2 (Illumina) for a 150 bp paired-end sequencing run using the NextSeq 500 sequencer 483 (Illumina). 484
Genome sequence assembly was performed using Geneious Prime software version 2019.1.3. 485
Paired read data sets were trimmed using the BBDuk (Decontamination Using Kmers) plugin 486 using a minimum Q value of 20. The genome for the ancestral PAO1 IC strain was de novo 487 assembled using the default automated sensitivity settings offered by the software. The 488 consensus sequence of PAO1 IC assembled in this manner was then used as the reference 489 sequence for mapping all of the PAO1 IC strains with multiple deletions. As a control, the 490 sequences were also mapped to the reference P. aeruginosa PAO1 sequence (NC_002516) to 491 verify deletion border coordinates. Coverage of these sequenced strains ranged from 66 to 143-492 fold, with an average of 98.3-fold. The sequenced P. aeruginosa environmental strains were also 493 mapped to the PAO1 (NC_002516) reference, while the sequenced E. coli strains were mapped 494
to the E. coli K-12 MG1655 reference sequence (NC_000913). Finally, sequenced P. syringae 495 strains were mapped to the P. syringae DC3000 (NC_004578) reference sequence, along with 496 the pDC3000A endogenous 73.5 kb plasmid sequence (NC_004633). All of the remaining 497 sequenced strains had > 100-fold coverage. All deletion junction sequences were manually 498 verified by the presence of multiple reads spanning the deletions, containing sequences from both 499 end boundaries. 500 WGS data was visualized using the BLAST Ring Image Generator (BRIG) tool 60 employing 501 BLAST+ version 2.9.0. In several cases, short sequences were aligned within previously 502
determined large deletions at redundant sequences such as transposase genes. Such 503 misrepresentations created by BRIG were manually removed to reflect the actual sequencing 504
data. 505
Data availability 506
Raw whole-genome sequencing data associated with Figures 1D, 3B , 4A, 4C, 4F, and 5A) has 507 been uploaded to GenBank (Submission number SUB6598604, accession number pending) and 508
is also available, along with bacterial strains, upon request from the corresponding author. an endogenous Type I-C system. Two survivors were isolated post-targeting using either WT 598 direct repeats flanking the spacer, or modified repeats. B) Editing efficiencies at targeted genomic 599 sites using homologous templates in a laboratory (PA14) and clinical (z8) strain of P. aeruginosa. 600
See Supplementary Table 3 for isolates with the deletion out of ten isolates assayed. B) Genotyping results for the Pseudomonas 703 aeruginosa environmental isolate using the 0.17 kb HDR template. Larger band corresponds to 704 the WT sequence, smaller band corresponds to a genome reduced by 0.17 kb. C) Genotyping 705 results of PAO1 IC AcrC1 lysogens after self-targeting induction in the presence or absence of 706 aca1 and a non-targeted control. Ten biological replicates per strain were assayed. gDNA was 707 extracted from each replicate and PCR analysis for the phzM gene (targeted gene, top row of 708 gels) or cas5 gene (non-targeted gene, bottom row) was conducted. Only cells that co-expressed 709 aca1 with the crRNA showed loss of the phzM band, indicating genome editing. All replicates had 710 a cas5 band, indicating successful gDNA extraction and target specificity for the phzM locus. 711 712 Supplementary Table 3 . Summary of HR-mediated genome editing experiments using the Type 724 I-F CRISPR-Cas3 system. Genes were targeted for deletion in the strains PA14 and z8. 725
Region Coordinates
Experiments targeted 4 single genes and 2 gene blocks, teg and rebB, that comprise X and Y 726 genes, respectively. Transformants were classified as 1) 'HR edits' that have the HR designed 727 deletion; 2) 'non-templated edits' that have a non-designed deletion encompassing the targeted 728 gene, 3) 'no edits' where the targeted gene is intact. (*) two colony morphologies with different 729 editing frequencies were obtained in this experiment. 730 731 Supplementary 
